Welcome
COVID-19 continues to pose a significant risk to older adults and people with chronic health conditions. Timely identification, diagnosis, and treatment can substantially improve patient outcomes, yet many eligible patients still miss opportunities for early intervention.
This free, self-paced course has been designed for busy healthcare professionals. Across five short modules (10–15 minutes each), you’ll gain practical, evidence-based strategies to improve the care of patients at high risk of severe COVID-19.
Developed by an international team of clinicians, behavioural scientists, and researchers, the course combines current clinical evidence with behavioural science tools to support effective communication, address treatment hesitancy, and provide culturally appropriate, person-centred care.
Before you begin, please complete the short pre-course assessment using the button below. After completing all five modules, we ask you to complete the post-course assessment to help us evaluate the course, improve future training, and download your Certificate of Completion. Both assessments take only a few minutes to complete.
Each module includes practical examples and downloadable resources to support learning and implementation in clinical practice.
Why shall I complete this training?
This course equips healthcare professionals with practical skills that extend beyond COVID-19, making it highly relevant across a range of diseases and high-risk patient populations.
1. Risk stratification and early intervention
Learn to identify high-risk patients, assess eligibility for treatment, and prioritise timely intervention.
These skills are directly applicable to other infectious diseases (e.g., influenza, RSV) and chronic conditions where early detection improves outcomes.
2. Behavioural science and patient engagement
Apply behaviour change techniques to address patient hesitancy, misconceptions, or low adherence.
Develop skills in culturally and linguistically appropriate communication, useful across all clinical contexts.
3. Clinical decision-making frameworks
Use case-based scenarios to develop structured reasoning and guideline-based decision-making.
These approaches are transferable to managing conditions such as atrial fibrillation, diabetes, and COPD exacerbations.
4. Digital and microlearning delivery
The modular, self-paced format, including online case scenarios and practical tools, can be adapted for other diseases or professional development initiatives.
5. Evaluation and reflective practice
Pre- and post-training assessments support self-reflection and continuous learning, applicable to any clinical topic or training programme.
Modules
¿Se están pasando por alto los pacientes con COVID-19 de alto riesgo? Mejorar la identificación temprana en la práctica
Por Astin Sokang, Universitas Kristen Krida Wacana, Indonesia; Triana Kesuma Dewi, Universitas Airlangga, Indonesia; Yuhang Zhu, Shandong Second Medical University, China; Gill ten Hoor, Maastricht University, Países Bajos En muchos adultos, la COVID-19 causa solo una...
Actuar pronto, mejores resultados: la importancia de la intervención temprana frente a la COVID-19 en pacientes de alto riesgo
Por İrem Berna Güvenç Erdoğan, Middle East Technical University, Turquía; Iga Palacz-Poborczyk, SWPS University, Polonia; Olga Perski, Stockholm University, Suecia; Sheson Tiwari, Psyfolks Education, India; Belgin Ünal, University of Michigan, Estados Unidos...
Prevenir las complicaciones de la COVID-19 en pacientes de alto riesgo mediante el cambio de comportamiento
Por David Simons, Pennsylvania State University; Ayşegül Bakır, Hacettepe University, Turquía; Johanna Nurmi, University of Helsinki, Finlandia Normalmente, la COVID-19 se describe en pasado y únicamente como una infección respiratoria. Pero la COVID-19 sigue siendo...
Vivir más allá de la COVID-19: gestionar los impactos a largo plazo en la salud
Por Dominika Kwasnicka, University of Melbourne, Australia, y Rizmina Rilwan, investigadora independiente de Sri Lanka La COVID-19 después de la fase aguda: lo que aún estamos aprendiendo Aunque la fase aguda de la COVID-19 ha sido el foco de la atención mundial, sus...
Uso de la ciencia del comportamiento para apoyar el diagnóstico y el tratamiento de la COVID-19 en grupos de alto riesgo
Por Tracy Epton, University of Manchester, Reino Unido; Lisa Marie Warner, MSB Medical School Berlin, Alemania; y Aleksandra Lazic, investigadora independiente de Belgrado, Serbia Trabajar con pacientes de alto riesgo en torno a la COVID-19 puede sentirse como...